Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Rapid and Effective: Spravato Promises New Possibilities in Battling Depression

Longview, WA (Newsworthy.ai) Thursday Jun 29, 2023 @ 11:10 AM Central —

In the ongoing battle against depression, a revolutionary medication called Spravato has emerged as a potential game-changer. Developed as a powerful treatment option, Spravato is making waves for its ability to alleviate depression symptoms more rapidly than traditional antidepressants.

Spravato's active ingredient is esketamine, derived from ketamine. Unlike conventional antidepressants, the medication works through a different mechanism, allowing patients to respond quicker. Studies have shown promising results, making Spravato a viable alternative for individuals seeking effective depression treatment.

Spravato's unique formulation offers hope for those struggling with depression," said experts. "Its rapid onset of action has shown great promise in alleviating the suffering experienced by patients."

However, Spravato is not a medication that can be self-administered. It is available exclusively by prescription and must be supervised by a healthcare professional in a healthcare setting. This ensures that patients receive the necessary care and monitoring while undergoing treatment.

According to experts, the importance of proper evaluation before considering Spravato. "Not everyone is a candidate for Spravato. To be eligible, individuals must have tried at least two other antidepressants without success. It is crucial to consult a healthcare provider to determine if Spravato is the right choice."

With depression affecting millions worldwide, Spravato represents a ray of hope for those who have struggled to find effective treatment options. By offering a medication that acts rapidly and differently from conventional antidepressants, Spravato brings a new level of optimism to the mental health field.

To find out if Spravato may be a viable solution for depression treatment, individuals and their healthcare providers are urged to have an open discussion. By exploring all available options, patients can take a step towards reclaiming their lives from the grip of depression.

About TMS-NW

TMS NW is a group of mental health professionals committed to providing advanced solutions for mental illness with TMS Treatment, Spravato, in person and through telehealth services. Our team completes thorough evaluations to help create your unique treatment plan.


This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.